Business / Finance

RSS

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Bristol-Myers Squibb Company today announced first quarter results that included strong sales and earnings growth, and several key R&D milestones—most notably U.S. regulatory approval for YERVOY. The company also confirmed guidance for the year.

30 Apr 2011

Coventry first quarter revenues increase 6.6% to $3.0 billion

Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended March 31, 2011.

30 Apr 2011

Polo Biology Global Group reports sales of $1,225,000 for fourth quarter 2010

Polo Biology Global Group Corporation today announced its financial results for the three months and twelve months ended December 31, 2010.

30 Apr 2011

Diversinet reports net loss of $1.1 million for first quarter 2011

Diversinet Corp., a leader in "connected and protected" mobile healthcare communications, reported its first quarter 2011 results for the period ended March 31, 2011. All dollar amounts are in U.S. dollars.

30 Apr 2011

Senomyx first-quarter 2011 revenues rise up 13%

Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.

30 Apr 2011

Claimsnet.com first quarter revenues decrease 1% to $573,000

Claimsnet.com inc., a leading provider of Internet-based business-to-business solutions for the healthcare industry, today reported its results for the first quarter of fiscal 2011, which ended March 31, 2011.

30 Apr 2011

Keryx Biopharmaceuticals reports net loss of $6.4 million for first quarter 2011

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.

30 Apr 2011

NeurogesX first quarter revenue is $3.2 million for 2011

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its first quarter ended March 31, 2011.

30 Apr 2011

QHR annual revenues increase 38% to $19.1 million for 2010

QHR Technologies Inc., a leader in the Canadian Healthcare Information Technology sector, is pleased to announce today the release of its annual audited financial statements for the year ended December 31, 2010.

30 Apr 2011

Aptilon annual revenue increases 111% to $33.5 million

Aptilon Corporation, a leader in online access, engagement and interaction with physicians and healthcare professionals on behalf of pharmaceutical and life sciences companies, today announced its financial results for the year ended December 31, 2010.

30 Apr 2011

Magellan reports net revenue of $692.8 million for first quarter 2011

Magellan Health Services, Inc. today reported financial results for the first quarter of 2011, as summarized below, and increased guidance for the full year.

30 Apr 2011

Noveko closes private placement for $595,104

Noveko International Inc. announces a first closing of $595,104 of its private placement. Additional closings are expected until May 23, 2011.

30 Apr 2011

HMS first quarter revenue increases 27% to $82.5 million

HMS Holdings Corp. Reports Record First Quarter 2011 Results

30 Apr 2011

Oncothyreon prices underwritten public offering of common stock

Oncothyreon Inc. today announced that it has priced an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $37.4 million.

29 Apr 2011

LifePoint Hospitals first quarter revenues increase 13.0% to $888.6 million

LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2011.

29 Apr 2011

Amerigroup first quarter total revenues increase 12.3% to $1.54 billion

Amerigroup Corporation today announced that net income for the first quarter of 2011 was $70.5 million, or $1.37 per diluted share, versus net income of $42.2 million, or $0.82 per diluted share, for the first quarter of 2010. Total revenues for the first quarter of 2011 increased 12.3% to $1.54 billion compared with $1.37 billion in the first quarter of 2010. Sequentially, total revenues increased 2.5% from the fourth quarter of 2010.

29 Apr 2011

China Pharmaceuticals net sales increase 28% to $34,184,906

China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals today announced its financial results for fiscal year ended December 31, 2010.

29 Apr 2011

Iroko Pharmaceuticals announces acquisition of iCeutica

Iroko Pharmaceuticals, LLC today announces that it has acquired iCeutica, Inc. to further strengthen Iroko's position as the leading developer of novel, low-dose non-steroidal anti-inflammatory drugs.

29 Apr 2011

HealthSpring reports net income of $44.2 million for first quarter 2011

HealthSpring, Inc. today announced its results for the first quarter ended March 31, 2011, which include the results of Bravo Health, Inc., acquired by the Company in November 2010.

29 Apr 2011

ZOLL Medical second quarter revenues increase 14% to $122.5 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the second quarter of fiscal 2011 increased 14% to $122.5 million, compared to revenues in the second quarter of last year of $107.1 million.

28 Apr 2011